BIOSTON
Dead / Cancelled — Cancelled — Section 8 (as of 20 Jun 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87171817
- Registration number
- 5623215
- Mark type
- Stylized text
- Filed
- 14 Sept 2016
- Published for opposition
- 31 Jan 2017
- Registered
- 04 Dec 2018
- Attorney of record
- Hyunsuk Min
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research in the field of chemistry; Research on food; Research on the subject of pharmaceuticals; Agricultural research; Agrochemical research services; Bacteriological research; Bacteriological research and testing; Bacteriological consultation and research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Cosmetics research; Cosmetics research for others; Food research; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of novel drugs; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Pharmaceutical research services; Physics research; Product research; Product research and development; Providing medical research and scientific research information in the field of oncology via the Internet; Scientific research; Scientific research and development; Technical research in the field of pharmaceutical studies
Owner
- INTODEWORLD, INC., BURLINGTON, MA, US
- BiOStON Therapeutics, Inc., BURLINGTON, MA, US
- BiOStON Therapeutics, Inc., BURLINGTON, MA, US
- BiOStON Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 20 Jun 2025 — CANCELLED SEC. 8 (6-YR)
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Mar 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2018 — USE AMENDMENT FILED
- 26 Sept 2018 — TEAS STATEMENT OF USE RECEIVED
- 16 Aug 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Apr 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Apr 2018 — SOU EXTENSION 2 GRANTED
- 28 Mar 2018 — SOU EXTENSION 2 FILED
- 24 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Apr 2018 — NOTICE OF REVIVAL - E-MAILED